The efficacy of selected bariatric surgery methods on lipid and glucose metabolism: a retrospective 12-month study

Bužga, Marek; Petřeková, Karin; Holéczy, Pavol; Kuča, Kamil

doi:10.21101/cejph.a4637

Cited by 6 publications

(10 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Based largely on between‐study comparisons, bariatric surgical procedures promote different levels of weight loss, which can have varying effects on outcomes (Table 2) (15,29,39,52,66,82). Individuals may experience inadequate weight loss or weight regain after bariatric surgery, with risk of comorbidities returning (47).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Tahrani

Morton

2022

Obesity

View full text Add to dashboard Cite

Obesity is a multifactorial chronic disease that is associated with increased risks of type 2 diabetes (T2D), cardiovascular disease, certain cancers, sleep apnea, subfertility, and mortality, among other complications (1). For adults, the World Health Organization (WHO) defines "overweight" and "obesity" as having BMI of 25 kg/m 2 or more and 30 kg/m 2 or more, respectively (2). According to WHO estimates, almost four in ten adults (39%) were overweight and more than one in ten (13%) had obesity in 2016 globally (2). As BMI does not reflect fat distribution, waist circumference provides further information about patient risks of T2D, hypertension, and cardiovascular disease, which increase with increasing BMI and waist circumference category (Table 1) (1). Risks of comorbidities and cutoff points for considering therapeutic intervention differ in Asian versus non-Asian populations, with BMI of 23 to 27.5 kg/m 2 conferring increased risk and BMI of 27.5 kg/m 2 or more conferring high risk in Asian individuals (3). Members of Black and some minority ethnic groups are also at increased risk of chronic health conditions at a lower BMI than the White population (BMI < 25 kg/m 2 ) (4).The global prevalence of obesity almost tripled between 1975 and 2016 (2), and it is increasingly becoming a public health priority.Overweight and obesity are responsible for a substantial disease burden and are associated with considerable direct costs (e.g., health care expenditure) and indirect costs (e.g., loss of productivity and gross domestic product [GDP]) (5,6). In 2014, 5% of deaths worldwide were attributable to obesity (7). Health expenditure associated with overweight/obesity is estimated to account for 2% to 8% of total health expenditure, although these values may be underestimates (5).Overweight and obesity and their consequences also negatively affect

show abstract

Section: Resultsmentioning

confidence: 99%

“…Based on these searches, 57 primary publications were identified for inclusion in this review (9,12,14‐68). One case study involving a single patient (67) and one abstract (68) were subsequently excluded (Figure 1).…”

Section: Methodsmentioning

confidence: 99%

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Tahrani

Morton

2022

Obesity

View full text Add to dashboard Cite

show abstract

“…In the present patients, the triglyceride concentration was significantly reduced at every check point compared to the pre-operative values. Other authors report the same at 12 months after sleeve gastrectomy (restriction), and even more so in patients treated by RYGB (reduction-restriction) [26].…”

Section: Discussionmentioning

confidence: 67%

Changes in Lipid Profile, Body Weight Variables and Cardiovascular Risk in Obese Patients Undergoing One-Anastomosis Gastric Bypass

Jiménez

Carbajo²,

López

et al. 2020

IJERPH

View full text Add to dashboard Cite

Morbid obesity has a direct impact on the development of cardiovascular disease. One-anastomosis gastric bypass (OAGB) is an effective surgical technique for the control of body weight and the reduction of cardiovascular risk. This work examines the change in weight loss, lipid profile and cardiovascular risk in 100 patients (71 women, 29 men), mean age 42.61 ± 11.33 years at 3, 6, 9, 12, 18 and 24 months after OAGB. At 24 months post-surgery, mean body weight was significantly reduced compared to pre-operative values (116.75 ± 22.19 kg vs. 69.66 ± 13.07 kg), as were mean total cholesterol (201.86 ± 44.60 mg/dL vs. 172.99 ± 32.26 mg/dL), LDL (Low-Density Lipoprotein) cholesterol (126.90 ± 39.81 mg/dL vs. 96.28 ± 26.99 mg/dL), triglycerides (138.05 ± 78.45 mg/dL vs. 76.04 ± 30.34 mg/dL) and cardiovascular risk (total cholesterol/HDL (High-Density Lipoprotein) cholesterol: 4.32 ± 1.24 vs. 2.93 ± 0.71), while the mean HDL cholesterol concentration was significantly higher (49.09 ± 14.16 mg/dL vs. 61.98 ± 14.86 mg/dL) (all p < 0.001). In conclusion, OAGB surgery led to significant reductions in body weight, a significant improvement in the lipid profile, and a reduction in cardiovascular risk.

show abstract

“…B/M surgery represents the most effective therapeutic tool for morbid obesity and a promising approach towards obesity-related comorbidities, because, unlike conservative treatment, it assures significant, quick and relatively sustainable weight loss [19,[22][23][24]. Although this effect is predominantly based on the desirable fat mass reduction, it may also be associated with a decrease of other body components, such as muscles and bones [10,19,20].…”

Section: Discussionmentioning

confidence: 99%

The risk of sarcopenia 24 months after bariatric surgery - assessment by dual energy X-ray absorptiometry (DEXA): a prospective study.

Pekař¹,

Pekařová²,

Bužga³

et al. 2020

Videosurgery and Other Miniinvasive Techniques

Self Cite

View full text Add to dashboard Cite

Introduction: Bariatric procedures lead to changes in body composition. Desired fat loss may be accompanied by decrease of muscle mass, thus raising the risk of sarcopenia. Aim: To detect the risk of sarcopenia in patients 24 months after different bariatric/metabolic (B/M) procedures by DEXA. Material and methods: Consecutive patients scheduled for a B/M procedure underwent DEXA scan and anthropometric assessment before and 24 months after surgery in a prospective manner. Obtained data were tested for significant differences (p < 0.05) to detect body composition changes and occurrence of sarcopenia. The International Physical Activity Questionnaire (IPAQ) was answered at 24 months to assess physical activity. Results: Nineteen patients were enrolled, with no drop-off at follow-up. Body mass index dropped from 42.4 ±6.3 to 30.3 ±4.9 kg/m 2 , with excess weight loss of 72 ±25% and substantial improvement of all relevant anthropometric measurements (p < 0.001). Significant changes in DEXA parameters were observed: fat mass index (19.5 ±4.7 vs. 12.1 ±3.7 kg/m 2), estimated visceral adipose area (235.8 ±70.0 vs. 126.5 ±50.4 cm 2), lean mass index (22.1 ±2.4 vs. 18.1 ±2.3 kg/m 2), appendage lean mass index (9.7 ±1.3 vs. 7.7 ±1.1 kg/m 2), bone mineral content (1.22 ±0.1 vs. 1.12 ±0.1 kg), Z score (2.32 vs. 0.96) and T score (0.58 vs.-0.58). A low level of physical activity was recorded at 24 months. Conclusions: B/M procedures lead to significant changes in body composition at 24 months after surgery. DEXA detects these changes effectively. Desired fat loss is associated with significant reduction of skeletal muscle and bone mineral mass. As such, patients after B/M surgery are at risk of sarcopenia. A low level of physical activity may also play a negative role.

show abstract

The efficacy of selected bariatric surgery methods on lipid and glucose metabolism: a retrospective 12-month study

Cited by 6 publications

References 25 publications

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

Changes in Lipid Profile, Body Weight Variables and Cardiovascular Risk in Obese Patients Undergoing One-Anastomosis Gastric Bypass

The risk of sarcopenia 24 months after bariatric surgery - assessment by dual energy X-ray absorptiometry (DEXA): a prospective study.

Contact Info

Product

Resources

About